User:MD-EPN/sandbox

Overview

Endpoints News is an American digital news publication focused on the biotechnology and pharmaceutical industries. Founded in 2016 by John Carroll and Arsalan Arif, it reports on drug development, regulatory affairs, and biotech investment. In 2023, the Financial Times acquired a controlling stake in Endpoints News to expand its coverage of the biopharmaceutical industry{{Cite news |date=2023-04-05 |title=CORRECTED-Financial Times acquires majority stake in medical publication Endpoints News (April 3) |url=https://www.reuters.com/article/technology/corrected-financial-times-acquires-majority-stake-in-medical-publication-endpoin-idUSL4N3662SJ/ |access-date=2025-06-19 |work=Reuters |language=en}}{{Cite web |title=Endpoints {{!}} FT Specialist - Specialist insight from the Financial Times |url=https://www.ftspecialist.com/en-gb/our-brands/biopharma-professionals/endpoints/ |access-date=2025-06-19 |website=www.ftspecialist.com |language=en-gb}}.

Drew Armstrong was appointed Executive Editor to oversee newsroom and editorial operations in 2022{{Cite web |title=Drew Armstrong |url=https://bcic.bio.org/speakers/drew-armstrong |access-date=2025-06-19 |website=CEO and Investor Conference 2025 |language=en-US}}.

Recognition

Endpoints News' reporting has been referenced in Semafor{{Cite news |title=American business leaders are turning on Trump — fast |url=https://www.semafor.com/article/02/27/2025/american-business-leaders-are-turning-on-trump-fast |archive-url=http://web.archive.org/web/20250518052603/https://www.semafor.com/article/02/27/2025/american-business-leaders-are-turning-on-trump-fast |archive-date=2025-05-18 |access-date=2025-06-19 |language=en}}, CNBC{{Cite web |last=Capoot |first=Annika Kim Constantino,Ashley |date=2025-02-04 |title=Healthy Returns: Why people quit weight loss and diabetes drugs within one year |url=https://www.cnbc.com/2025/02/04/healthy-returns-why-people-quit-weight-loss-diabetes-drugs.html |url-status=live |access-date=2025-06-19 |website=CNBC |language=en}},The New York Times{{Cite news |last=Stockman |first=Farah |last2=Barker |first2=Kim |date=2020-04-12 |title=How a Premier U.S. Drug Company Became a Virus ‘Super Spreader’ |url=https://www.nytimes.com/2020/04/12/us/coronavirus-biogen-boston-superspreader.html |access-date=2025-06-19 |work=The New York Times |language=en-US |issn=0362-4331}}, Wall Street Journal{{Cite news |last=Grogan |first=Joe |date=2022-11-03 |title=Opinion {{!}} The Inflation Reduction Act Is Already Killing Potential Cures |url=https://www.wsj.com/articles/the-inflation-reduction-act-killing-potential-cures-pharmaceutical-companies-treatment-patients-drugs-prescriptions-ira-manufacturers-11667508291 |access-date=2025-06-19 |work=Wall Street Journal |language=en-US |issn=0099-9660}}, and NPR{{Cite news |last=Hubbard |first=Halisia |date=2022-11-25 |title=Twitter has lost 50 of its top 100 advertisers since Elon Musk took over, report says |url=https://www.npr.org/2022/11/25/1139180002/twitter-loses-50-top-advertisers-elon-musk |access-date=2025-06-19 |work=NPR |language=en}}.

Awards received:

  • SABEW Best in Business HealthTech newsletter{{Cite web |title=2024 Best in Business Awards |url=https://sabew.org/contestsawards/best-in-business/ |access-date=2025-06-19 |website=SABEW |language=en-US}}
  • 2025 Jesse H. Neal Awards for Best eNewsletter and Best Generative AI Content{{Cite web |title=2025 Neal Awards Winners |url=https://siia.net/neals/2025-neal-awards-winners/ |access-date=2025-06-19 |website=Neals |language=en-US}}

References

__FORCETOC__